Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Sales and Divestitures: 2015-2017

Historic Gains from Sales and Divestitures for Ocugen (OCGN) over the last 3 years, with Dec 2017 value amounting to $1,889.

  • Ocugen's Gains from Sales and Divestitures fell 42.77% to $1,889 in Q4 2017 from the same period last year, while for Dec 2017 it was $1,889, marking a year-over-year decrease of 42.77%. This contributed to the annual value of $1,889 for FY2017, which is 42.77% down from last year.
  • Ocugen's Gains from Sales and Divestitures amounted to $1,889 in Q4 2017, which was down 0.00% from $1,889 recorded in Q3 2017.
  • Ocugen's Gains from Sales and Divestitures' 5-year high stood at $3,303 during Q4 2015, with a 5-year trough of $1,889 in Q2 2015.
  • In the last 3 years, Ocugen's Gains from Sales and Divestitures had a median value of $1,889 in 2017 and averaged $2,203.
  • Data for Ocugen's Gains from Sales and Divestitures shows a maximum YoY crashed of 42.77% (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows Ocugen's Gains from Sales and Divestitures stood at $3,303 in 2015, then declined by 0.06% to $3,301 in 2016, then plummeted by 42.77% to $1,889 in 2017.
  • Its Gains from Sales and Divestitures was $1,889 in Q4 2017, compared to $1,889 in Q3 2017 and $1,889 in Q2 2017.